These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2008289)

  • 1. Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin.
    van der Hulst RJ; Boeschoten EW; Nielsen FW; Struijk DG; Dreschler WD; Tange RA
    ORL J Otorhinolaryngol Relat Spec; 1991; 53(1):19-22. PubMed ID: 2008289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis.
    Tokgoz B; Ucar C; Kocyigit I; Somdas M; Unal A; Vural A; Sipahioglu M; Oymak O; Utas C
    Nephrol Dial Transplant; 2011 Dec; 26(12):4073-8. PubMed ID: 21551083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing thresholds in CAPD patients.
    Morton LP; Reynolds L; Zent R; Rayner BL
    Adv Perit Dial; 1992; 8():150-2. PubMed ID: 1361774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between hearing loss and peritonitis frequency and administration of ototoxic intraperitoneal antibiotics in patients with CAPD.
    Tokgoz B; Somdas MA; Ucar C; Kocyigit I; Unal A; Sipahioglu MH; Oymak O; Utas C
    Ren Fail; 2010 Jan; 32(2):179-84. PubMed ID: 20199179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin and netilmicin as first line treatment of peritonitis in CAPD patients.
    Brauner L; Kahlmeter G; Lindholm T; Simonsen O
    J Antimicrob Chemother; 1985 Jun; 15(6):751-8. PubMed ID: 4030537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD).
    Friedland JS; Iveson TJ; Fraise AP; Winearls CG; Selkon JB; Oliver DO
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():77-81. PubMed ID: 2292548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin administration in continuous ambulatory peritoneal dialysis: the risk of ototoxicity.
    Gendeh BS; Gibb AG; Aziz NS; Kong N; Zahir ZM
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):551-8. PubMed ID: 9560111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis.
    Gendeh BS; Said H; Gibb AG; Aziz NS; Kong N; Zahir ZM
    J Laryngol Otol; 1993 Aug; 107(8):681-5. PubMed ID: 8409715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.
    Blunden M; Zeitlin D; Ashman N; Fan SL
    Nephrol Dial Transplant; 2007 Jun; 22(6):1714-9. PubMed ID: 17369615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute massive gentamicin intoxication in a patient with end-stage renal disease.
    Lu CM; James SH; Lien YH
    Am J Kidney Dis; 1996 Nov; 28(5):767-71. PubMed ID: 9158219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between oral ciprofloxacin and intra-peritoneal vancomycin and gentamicin in the treatment of CAPD peritonitis.
    Bennett-Jones DN; Russell GI; Barrett A
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():73-6. PubMed ID: 2292547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis.
    Lye WC; Lee EJ; van der Straaten J
    Perit Dial Int; 1993; 13 Suppl 2():S348-50. PubMed ID: 8399607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritonitis in continuous ambulatory peritoneal dialysis. Culture of peritoneal dialysate fluid].
    Møller JK; Hagelskjaer LH
    Ugeskr Laeger; 1996 Apr; 158(18):2538-41. PubMed ID: 8686007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?
    Bailie GR; Morton R; Ganguli L; Keaney M; Waldek S
    Nephron; 1987; 46(3):316-8. PubMed ID: 3627326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Gucek A; Bren AF; Hergouth V; Lindic J
    Adv Perit Dial; 1997; 13():218-20. PubMed ID: 9360685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peritonitis among patients treated with continuous ambulatory peritoneal dialysis].
    Bistrup C; Siboni AH; Pedersen RS
    Ugeskr Laeger; 1995 Jul; 157(28):4023-6. PubMed ID: 7645077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peritonitis in continuous ambulatory peritoneal dialysis. An evaluation of the empiric initial antibiotic treatment].
    Hagelskjaer LH; Møller JK
    Ugeskr Laeger; 1996 Apr; 158(18):2532-7. PubMed ID: 8686006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Beaman M; Solaro L; McGonigle RJ; Michael J; Adu D
    Nephron; 1989; 51(1):51-5. PubMed ID: 2644565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.